Evidence map›Paper›PMID 27564721›Full record

ArticleEye (London, England)2016

TGFβ induces BIGH3 expression and human retinal pericyte apoptosis: a novel pathway of diabetic retinopathy.

B S Betts-Obregon, A A Mondragon, A S Mendiola, R G LeBaron, R Asmis, T Zou, F Gonzalez-Fernandez, A T Tsin

Open access · bronzeAbstract read
In one paragraph

Article in Eye (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. TGF-β Signaling Pathways in the Development of Diabetic Retinopathy.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Involvement of TGFβ signaling pathway in oxidative stress and diabetic retinopathy.Archives of clinical and experimental ophthalmology · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

B S Betts-ObregonDepartment of Biology, The University of Texas at San Antonio, San Antonio, TX, USA.
A A MondragonDepartment of Biology, The University of Texas at San Antonio, San Antonio, TX, USA.
A S MendiolaDepartment of Biology, The University of Texas at San Antonio, San Antonio, TX, USA.
R G LeBaronDepartment of Biology, The University of Texas at San Antonio, San Antonio, TX, USA.
R AsmisDepartment of Biochemistry, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
T ZouDepartments of Ophthalmology and Pathology&Anatomic Sciences, State University of New York at Buffalo, Buffalo, NY, USA.
F Gonzalez-FernandezDepartments of Ophthalmology and Pathology&Anatomic Sciences, State University of New York at Buffalo, Buffalo, NY, USA.
A T TsinDepartment of Biology, The University of Texas at San Antonio, San Antonio, TX, USA.
The University of Texas at San Antonio · USThe University of Texas Health Science Center at San Antonio · USG.V. (Sonny) Montgomery VA Medical Center · USUniversity at Buffalo, State University of New York · US

Funding

Research Resource for Human Organs and Tissues (U42)U42OD011158 · OD · NATIONAL DISEASE RESEARCH INTERCHANGE · PI BELL, THOMAS J · 2012 to 2025
$25.0M
UTSA RISE Research Training ProgramR25GM060655 · NIGMS · UNIVERSITY OF TEXAS SAN ANTONIO · PI BAREA-RODRIGUEZ, EDWIN J · 2000 to 2022
$21.6M
RCMI Center for Interdiscplinary Health Research CIHRG12MD007591 · NIMHD · UNIVERSITY OF TEXAS SAN ANTONIO · PI PERRY, GEORGE · 2012 to 2016
$10.4M
IRBP--STRUCTURE/FUNCTIONR01EY009412 · NEI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI GHOSH, DEBASHIS, GONZALEZ-FERNANDEZ, FEDERICO · 1999 to 2011
$3.0M
Role of Glutathione Reductase and Macrophage OncosisR01HL070963 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ASMIS, RETO H.R. · 2002 to 2010
$2.8M
NEI NIH HHS R01 EY009412NHLBI NIH HHS R01 HL070963NIGMS NIH HHS R25 GM060655NIH HHS U42 OD011158NIMHD NIH HHS G12 MD007591
6 · The paper itself

Abstract

PurposeOne of the earliest hallmarks of diabetic retinopathy is the loss of retinal pericytes. However, the mechanisms that promote pericyte dropout are unknown. In the present study, we propose a novel pathway in which pericyte apoptosis is mediated by macrophages, TGFβ and pro-apoptotic BIGH3 (TGFβ-induced Gene Human Clone 3) protein.Patients and methodsTo elucidate this pathway, we assayed human retinal pericyte (HRP) apoptosis by TUNEL assay, BIGH3 mRNA expression by qPCR, and BIGH3 protein expression by western blot analysis. HRP were treated with BIGH3 protein, TGFβ1 and TGFβ2 and inhibition assays were carried out by blocking with antibodies against BIGH3. The distribution of BIGH3 and CD68

Indexed as

Antigens, CDAntigens, Differentiation, MyelomonocyticArteriolesbetaIG-H3 ProteinBlotting, WesternCD68 MoleculeCells, CulturedDiabetes Mellitus, Type 2Diabetic RetinopathyExtracellular Matrix ProteinsHumansMacrophagesPericytesPolymerase Chain ReactionRetinaRetinal VesselsAntigens, CDAntigens, Differentiation, MyelomonocyticbetaIG-H3 ProteinCD68 antigen, humanCD68 MoleculeExtracellular Matrix ProteinsRNA, MessengerTransforming Growth Factor betaTransforming Growth Factor beta1Transforming Growth Factor beta2

Identifiers

PMID27564721
PMCPMC5177749
OpenAlexW2512157503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.